Review explores the complexities of infectious disease outcomes through a balanced perspective, emphasizing the interplay between pathogenic microbes and host conditions, challenging the traditional germ-disease theory by proposing a more integrated view that considers both pathogen virulence and host immunity’s impact on disease manifestation.
Amgen plans further $200M investment in new tech facility in India
Amgen said it will spend an additional $200 million on its new technology center in Hyderabad, India, throughout 2025, with other investments to come over
February 25, 2025